Generics 57

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ursodeoxycholic acid manufacturers

57 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

57 products found

ursodeoxycholic acid

Tablets, film coated 150 mg, 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #22627
This pharmaceutical company was founded in 2007 and has two manufacturing facilities strategically located in India. They boast over 1,800 products spanning a range of therapeutic areas, including those focused on dermatology, pain management, and possibly central nervous system disorders based on the listed divisions. The company produces both prescription medications and over-the-counter drugs, utilizing diverse dosage forms such as tablets and capsules. They maintain a strong national network for distribution and a global presence. GMP certifications are likely held due to their focus on quality manufacturing practices.

Manufacturer usually replies in 5 days

ursodeoxycholic acid

Tablets 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Unavailable markets
India
Manufacturer #18850
This pharmaceutical company boasts over two decades of experience in manufacturing generic drugs and offering third-party manufacturing services. They have a dedicated team of experienced professionals overseeing operations, marketing, and sales across the EU and North America. Their own manufacturing unit ensures quality control, adhering to WHO GMP compliance. The company focuses on several key therapy areas, including neurology and pain management, with a range of principal dosage forms such as gels. They hold product patents and are trusted by leading physicians in both urban and rural areas.

Manufacturer usually replies in 2 days

ursodeoxycholic acid

Tablets 150 mg, 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21177
This company, established in the 1980s, operates within South Asia, specializing in the manufacture and supply of pharmaceutical products. Their offerings include tablets, capsules, eye, ear, and nasal drops, as well as oral and injectable suspensions. The company holds EU and US GMP approvals, signifying adherence to high manufacturing standards. Their production lines cater to a diverse range of therapeutic areas, with a focus on infectious diseases, pain management, and ophthalmology. The company boasts a sizable workforce and has a global reach, catering to markets across the world. They are recognized for their commitment to quality, utilizing high-grade chemicals and advanced machinery for production. The company emphasizes its track record in providing quality pharmaceutical products, underscoring its experience in the industry.

Manufacturer usually replies in 5 days

Want to see all 57 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Ursodeoxycholic acid is a bile acid used to treat gallstones as well as to treat and prevent the progression of cystic fibrosis-related liver disorders. Suppliers of ursodeoxycholic acid market it in the form of 150mg, 250mg and 500mg oral tablets and capsules. The market for ursodeoxycholic acid is relatively competitive, populated with numerous manufacturing companies and suppliers. The largest manufacturers of ursodeoxycholic acid market globally are companies Mitsubishi Tanabe Pharma, Daewoong Chemical, and PharmaZell, Glenmark Pharmaceuticals, Dipharma Francis, Errengierre, and Grindeks. Ursodeoxycholic acid suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified ursodeoxycholic acid manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 50 (250mg) tablets of ursodeoxycholic acid fall into an approximate range of 12,00 EUR to 15,00 EUR, whereas the equivalent amount of 500mg tablets cost from 25,00 EUR to 30,00 EUR.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible